Fox Chase Cancer Center News

PHILADELPHIA (January 18, 2023)—Joel Helmke, MSHP, FACHE, chief operating officer of Fox Chase Cancer Center, has been named Vice Chair of the Board of Directors of the Alliance of Dedicated Cancer Centers (ADCC). The trade association represents 10 of the nation’s leading cancer hospitals, including Fox Chase.

PHILADELPHIA (January 17, 2023)—Fox Chase Cancer Center has successfully renewed its accreditation with the National Accreditation Program for Breast Centers (NAPBC), making it the fifth consecutive time Fox Chase has received accreditation.

PHILADELPHIA (January 16, 2023)—Lisa Liu, a third year medical student at the Lewis Katz School of Medicine at Temple University, recently received a 2023 Conquer Cancer Merit Award from the American Society of Clinical Oncology (ASCO) for research that will be presented at an upcoming meeting.

PHILADELPHIA (January 16, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Mitchell Fane, PhD, as an assistant professor in the Cancer Signaling and Microenvironment research program.

PHILADELPHIA (January 16, 2023)— Roland L. Dunbrack Jr., PhD, director of the Molecular Modeling Facility at Fox Chase Cancer Center, recently announced the availability of a new database that contains clusters of homologous protein assembly structures observed in independent structure experiments found in the Protein Data Bank (PDB).

PHILADELPHIA (December 27, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Lindsey B. Taylor, MD, as an assistant professor in the Department of Hematology/Oncology and the Breast Cancer and Hematology Programs.

PHILADELPHIA (December 22, 2022)—The Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center are pleased to announce the hiring of Lucia Borriello, PhD, as an assistant professor in the Department of Cancer and Cellular Biology at Temple. In addition to her primary position at Temple, Borriello will hold a dual appointment in the Cancer Signaling and Epigenetics research program at Fox Chase.

PHILADELPHIA (December 22, 2022)—Research has shown that human immune function is highly correlated with the microorganisms living in the gastrointestinal tract. These microorganisms, known as the microbiome, can consequently impact whether a patient develops cancer and how they respond to treatment.